Does niacinamide do anything for skin? For blotchy pigment, the trials say a modest yes
A split-face melasma trial put niacinamide within reach of prescription hydroquinone with fewer side effects. But much of the anti-ageing evidence comes from the ingredient's own manufacturers.
| Group | Value (%) |
|---|---|
| Niacinamide 4% | 44 |
| Hydroquinone 4% | 55 |
Niacinamide is one of the few cosmetic actives with human trial evidence behind a specific claim: in a head-to-head study it lightened melasma nearly as well as prescription hydroquinone, with fewer side effects [s2]. Where it is weaker is the broad anti-ageing promise on the bottle, much of which traces back to studies run by the companies that sell the ingredient [s3].
The pigmentation evidence is the real evidence
The clearest result comes from a split-face trial in 27 people with melasma, who applied 4% niacinamide to one side of the face and 4% hydroquinone — the long-standing prescription lightening agent — to the other for eight weeks [s2]. Good-to-excellent improvement was seen in 44% of patients with niacinamide against 55% with hydroquinone [s2]. Side effects were less common on the niacinamide side, at 18% versus 29% [s2]. Biopsies showed niacinamide reduced mast-cell infiltrate and improved solar elastosis in the treated skin [s2]. Both sides were also protected with sunscreen throughout, so the comparison is niacinamide-plus-sunscreen against hydroquinone-plus-sunscreen, not either agent working alone [s2].
That is a real finding with a real comparator. Niacinamide did not beat hydroquinone, but landing within about ten points of the standard drug while irritating less is a meaningful result for an over-the-counter ingredient. A 2021 review of the ingredient's mechanisms reports that topical niacinamide inhibits pigmentation, enhances the skin barrier and extracellular matrix, and reduces the progression of skin ageing in clinical trials — while cautioning that there is no convincing evidence it acts on any specific molecular target, and that it more likely works by holding the skin's normal redox balance in place [s1].
Where the anti-ageing claims come from
The wrinkle-and-radiance side of the niacinamide story is thinner, and its most-cited trial illustrates why the evidence has to be read with the funding in view.
In that study, 50 women applied 5% niacinamide to half the face and a vehicle control to the other half, twice daily for 12 weeks, in a double-blind design [s3]. It reported significant improvements for niacinamide in fine lines and wrinkles, hyperpigmented spots, red blotchiness and skin sallowness, plus better elasticity measured by cutometry [s3]. Those are genuine, if modest, half-face results. The caveat is the authorship: the study was conducted by scientists at the Procter & Gamble Company, which sells niacinamide skincare [s3]. That does not make the data wrong, but a manufacturer's in-house trial is not the same tier of evidence as independent replication, and much of the anti-ageing literature for the ingredient sits in this category.
What that means for a buyer
Niacinamide is one of the better-evidenced things in a serum, and the evidence is strongest for the least glamorous claim: evening out pigmentation and blotchiness [s1][s2]. The barrier-support claim is backed by the same review, which credits niacinamide with strengthening the skin barrier and extracellular matrix [s1]. The anti-ageing claims are real in direction but modest in size and disproportionately manufacturer-generated [s3]. It is a sensible ingredient with a narrow, honest case — and that case is smaller than the label suggests.
This article is informational and is not medical advice. Melasma and persistent pigmentation have several causes and treatments, and evaluating them belongs with a clinician.
Sources
- [s1] Mechanistic Basis and Clinical Evidence for the Applications of Nicotinamide (Niacinamide) to Control Skin Aging and Pigmentation — Antioxidants, August 2021. https://doi.org/10.3390/antiox10081315
- [s2] A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma — Dermatology Research and Practice, 2011. https://doi.org/10.1155/2011/379173
- [s3] Niacinamide: A B vitamin that improves aging facial skin appearance — Dermatologic Surgery, July 2005. https://pubmed.ncbi.nlm.nih.gov/16029679/
Sources
- Mechanistic Basis and Clinical Evidence for the Applications of Nicotinamide (Niacinamide) to Control Skin Aging and Pigmentation — Antioxidants , August 21, 2021
- A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma — Dermatology Research and Practice , July 1, 2011
- Niacinamide: A B vitamin that improves aging facial skin appearance — Dermatologic Surgery , July 1, 2005
More on
Melasma is driven by sun and hormones on ageing skin — and no cream fully clears it
The brown facial patches come from overactive pigment cells in sun-aged skin. Triple-combination cream beats hydroquinone alone (risk ratio 1.58) and tranexamic acid helps, but relapse is the rule.
Dark spots and melasma: the creams the trials back, and what newer studies only hint at
Sun-driven brown patches are hard to shift. A Cochrane review found a triple-combination cream beat hydroquinone alone; newer meta-analyses point to tranexamic acid and PRP, on thinner evidence.
Do hyaluronic acid serums work? They hold water at the surface, and the size matters
Short trials show topical hyaluronic acid improves skin hydration and, in low-molecular-weight forms, wrinkle depth. It is a humectant on the surface, not a replacement for the acid skin loses with age.
Do vitamin C serums work? Split-face trials show smoothing, but the evidence is thin
Topical vitamin C is a real antioxidant that helps skin build collagen. Split-face studies show measurable smoothing, but a systematic review found only seven usable trials, almost all mixing it with other actives.